NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its second quarter revenues rose 4 percent year over year, falling slightly short of the consensus Wall Street estimate.

The company's total revenue for the three months ended June 30 was $85.5 million, compared with $82.0 million in the second quarter of 2016. Analysts on average had predicted revenues of $86.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.